Drugs Containing Excipient (Inactive Ingredient) MICA

Branded drugs containing MICA excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Haleon US Holdings LLC	NEXIUM 24HR	esomeprazole magnesium	0573-2451	MICA
MDD US Operations LLC a subsidiary of Supernus Pharmaceuticals Inc	XADAGO	safinamide mesylate	27505-110	MICA
Colgate-Palmolive Company	COLGATE TOTAL WHITENING	sodium fluoride and triclosan	35000-002	MICA
Colgate-Palmolive Company	COLGATE TOTAL ADVANCED FRESH PLUS WHITENING	sodium fluoride and triclosan	35000-004	MICA

Generic drugs containing MICA excipient

Company	Ingredient	NDC	Excipient
Haleon US Holdings LLC	esomeprazole magnesium	0573-2451	MICA
Rite Aid Corporation	nicotine polacrilex	11822-1720	MICA
MDD US Operations LLC a subsidiary of Supernus Pharmaceuticals Inc	safinamide mesylate	27505-110	MICA
Colgate-Palmolive Company	sodium fluoride and triclosan	35000-002	MICA

Market Dynamics and Financial Trajectory for MICA Pharmaceutical Excipient

Last updated: February 25, 2026

What Is the Market Size and Growth Outlook for MICA?

MICA (referred to as Microcrystalline Cellulose or MCC in some contexts) is a widely used pharmaceutical excipient for tablet binders, fillers, and disintegrants. The global MCC market was valued at approximately USD 1.4 billion in 2022. Compound annual growth rate (CAGR) estimates project it to reach USD 2.2 billion by 2030, with a CAGR of 5.8% (2019–2030) [1].

The growth attributes to increasing drug formulation complexity, rising demand for generic oral solid doses, and expanding pharmaceutical manufacturing capacity.

Market Segment Drivers

• Oral solid dosage form dominance: Representing over 80% of pharmaceutical production volume, driving MCC demand.
• Regulatory approvals: Favor MCC products with GRAS (Generally Recognized As Safe) status.
• China and India markets: Rapidly expanding manufacturing sectors, with regional MCC markets growing at CAGR of 7% [2].

Regional Breakdown (2022)

Region	Market Share	Growth Rate (2022–2030)
North America	32%	4.9%
Europe	27%	5.2%
Asia Pacific	29%	7.1%
Rest of World	12%	4.5%

What Are the Key Market Drivers and Constraints?

Drivers

• Rising prevalence of chronic diseases: Increased demand for oral solid medications.
• Growth in generic formulations: MCC used to produce cost-effective pharmaceuticals.
• Technological advancements: Improved MCC grades enhance manufacturability and stability.

Constraints

• Raw material pricing volatility: Cellulose sources (wood pulp and cotton) face supply chain disruptions.
• Regulatory hurdles: Strict testing and approval processes, particularly in the U.S. and EU.
• Environmental policies: Push for sustainable sourcing affects production costs and practices.

How Do Competitive Dynamics Affect Financial Trajectory?

Leading Manufacturers

Company	Market Share (%)	Key Products	Geographic Focus
FMC Corporation	26%	Avicel MCC series	North America, Europe
Asahi Kasei Corporation	18%	Primarily MCC grades	Asia-Pacific
SigACHI Industries	10%	Low and high viscosity MCC	India, Asia-Pacific
JRS Pharma GmbH	8%	Specialty MCC grades	Europe, North America
Otros	38%	Fragmented market share	Global

Market Entry and Innovation

• Vertical integration increases control over raw material costs.
• Product portfolio diversification enables access to niche markets (e.g., ultra-low or high viscosity MCCs).
• Regulatory compliance investments improve market access.

Revenue Projections

• The top five companies’ revenues for MCC segment exceeded USD 4.2 billion in 2022.
• The market is expected to grow at a weighted CAGR of around 6%, with high-margin innovation products contributing significantly [3].

What Are Financial Metrics and Investment Opportunities?

Revenue Trends

• Leading OEMs report mid-single to high-single digit growth in MCC sales.
• Innovative MCC formulations, such as modified grades (e.g., pre-gelatinized MCC), command premium prices—marking a potential revenue uptick.

Pricing Dynamics

• Raw material prices influence MCC product prices, affecting gross margins.
• Market competition suppresses price inflation, but premium-grade MCCs retain higher margins.

Parameter	2022 data	Projected 2030 data
Average MCC Price (USD/ton)	3,200	3,600 (due to innovation)
Raw Material Cost (% production)	70%	72%
Gross Margin (%)	35–40%	Approx. 38–42%

Investment Opportunities

• R&D in sustainable sourcing: Potential for cost reduction and regulatory advantages.
• High-performance MCC grades: Serve emerging markets with specialized needs.
• Regional expansion: Focus on Asia-Pacific for volume growth.

What Are the Regulatory and Supply Chain Factors Affecting the Market?

Regulatory Milestones

• MCC approved by the FDA for oral and topical formulations.
• European Pharmacopoeia standards for MCC have been harmonized to facilitate trade.

Supply Chain Considerations

• Heavy dependence on cotton and wood pulp as raw materials.
• Disruptions (e.g., global pandemic) can impact production capacity.
• Increased focus on sustainability may prompt investments in alternative cellulose sources.

Key Takeaways

• The MCC market is expanding due to greater demand in oral solid pharmaceuticals.
• Regional growth varies, with Asia-Pacific leading.
• Competition is consolidating around key players, but innovation remains essential.
• Raw material costs and regulatory changes influence margins and product development.
• Investment in sustainable supply chains and high-performance MCC grades offers growth potential.

FAQs

1. What distinguishes MCC from other pharmaceutical excipients?
   MCC offers high compatibility with APIs, compressibility, stability, and ease of manufacturing, making it suitable for a wide range of formulations.

2. Which regions are the primary growth markets for MCC?
   Asia-Pacific leads, especially India and China, due to expanding pharmaceutical manufacturing capacities.

3. How does regulatory approval impact MCC market prospects?
   Regulatory approvals, including FDA and EMA, enable MCC to be used in a broad range of pharmaceutical products, sustaining demand.

4. What technological innovations are influencing MCC development?
   Innovations include pre-gelatinized MCC, low-viscosity grades for high-speed manufacturing, and eco-friendly sourcing methods.

5. What are the main risks facing investments in MCC manufacturing?
   Raw material price volatility, regulatory shifts, and environmental sustainability pressures pose significant risks.

---

References

[1] MarketsandMarkets. (2023). Microcrystalline Cellulose Market by Grade, Application, and Region: Global Forecast to 2030.
[2] Grand View Research. (2022). Pharmaceutical Excipient Market Size, Share & Trends Analysis Report.
[3] Bloomberg Intelligence. (2023). Pharmaceuticals & Biotech Industry Data and Trends.